"In 2020 — after three years of immunosuppression — when I learned of mRNA vaccine research for MS, I was relieved," writes ...

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for ...

FDA officials stopped publication of studies backing COVID-19 and shingles vaccine safety, citing data concerns.

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of ...

The recent hantavirus outbreak has terrified people around the world, and understandably so. More than anything, however, ...

Randomized trial shows superiority in adults 50 and older ...

After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.

A new mRNA flu vaccine, singing mice and doctors find what may be behind restless leg syndrome. Here are your health ...

The Food and Drug Administration (FDA) has withdrawn studies that suggested COVID-19 and shingles vaccines were safe and ...

Moderna shares rally as investors bet on recent Hantavirus outbreak accelerating the biotech firm’s path to profitability.